Could a new dose of selexipag help kids with rare lung disease?
NCT ID NCT03492177
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study is testing the safety and right dose of a drug called selexipag in children aged 2 to 17 with pulmonary arterial hypertension (PAH), a serious condition where blood pressure in the lungs is too high. The goal is to find a dose that works like the adult version. The study involves 63 children and is currently active but not recruiting new participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Almazov National Medical Research Center Of The Ministry Of Health Of The Russian Federation
Saint Petersburg, 197341, Russia
-
Beijing Anzhen Hospital
Beijing, 100029, China
-
CHU Arnaud de Villeneuve
Montpellier, 34295, France
-
Centre Hospitalier Sainte Justine
Montreal, Quebec, H3T 1C4, Canada
-
Children'S Hospital Cardiac Care Center University Of Colorado
Aurora, Colorado, 80045, United States
-
Chu Hopital Des Enfants
Toulouse, 31059, France
-
Gottsegen Gyorgy Orszagos Kardiologiai Intezet, Felnott kardiologiai osztaly
Budapest, 1096, Hungary
-
Great Ormond Street Hospital
London, WC1N 3JH, United Kingdom
-
Health Institution 4Th City Children'S Clinical Hospital
Minsk, 220118, Belarus
-
Hôpital Necker - Enfants Malades
Paris, 75015, France
-
Institut Jantung Negara (National Heart Institute)
Kuala Lumpur, 50400, Malaysia
-
Institut Za Zdravstvenu Zastitu Majke I Deteta Srbije Dr Vukan Cupic
Belgrade, 11070, Serbia
-
Kazan State Medical University
Kazan', 420059, Russia
-
Lviv Regional Clinical Hospital
Lviv, 79010, Ukraine
-
Moscow Scientific Research Institute For Pediatrics And Childrens Surgery Of Rosmedtechnologies
Moscow, 125412, Russia
-
Municipal Enterprise Of The Dnipropetrovsk Regional Council
Dnipro, 49070, Ukraine
-
Municipal Institution Of The Zaporizhzhya Regional Council
Zaporizhzhya, 69063, Ukraine
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Saint Petersburg State Pediatric Medical University
Saint Petersburg, 194100, Russia
-
Samara Regional Clinical Cardiological Dispensary
Samara, 443070, Russia
-
Sarawak Heart Center
Kota Samarahan, 94300, Malaysia
-
Schneider Children's Medical Center
Petach Tikvah, Israel
-
Scientific and Research Institution of Cardiovascular Diseases Complex Problems
Kemerovo, 650002, Russia
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
Shanghai Childrens Medical Center
Shanghai, 200127, China
-
Sheba Medical Center
Ramat Gan, 52621, Israel
-
State Institution Of The Ministry Of Health Of Ukraine
Kiev, 04050, Ukraine
-
State Institution Republican Scientific And Practical Center For Pediatric Surgery
Minsk, 220013, Belarus
-
UZ Gent
Ghent, 9000, Belgium
-
University of Iowa Hospital
Iowa City, Iowa, 52242, United States
-
Universitätsklinikum Freiburg Zentrum
Freiburg im Breisgau, 70106, Germany
-
Univerzitetska Dečja Klinika
Belgrade, 11000, Serbia
-
Wojewodzki Szpital Specjalistyczny We Wroclawiu
Wroclaw, 51 124, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill ease the strain of pulmonary arterial hypertension?
- Could a gut bacteria transplant ease a rare lung disease?
- Can a diabetes drug help the heart burn fuel better in pulmonary hypertension?
- Can a smartwatch replace the clinic walk test for lung disease patients?
- Blood particles may reveal hidden clues to scleroderma complications
- Heart scans may soon replace Needle-Based catheter tests